(Q40709031)

23 September 2017

title

The effect of bone morphogenetic protein-2 expression on the early fate of skeletal muscle-derived cells (English)

1 reference

23 September 2017

1 reference

Musgrave DS

1

1 reference

23 September 2017

Pruchnic R

2

1 reference

23 September 2017

Wright V

3

1 reference

23 September 2017

Bosch P

4

1 reference

23 September 2017

Ghivizzani SC

5

1 reference

23 September 2017

Robbins PD

6

1 reference

23 September 2017

Huard J

7

1 reference

23 September 2017

publication date

1 May 2001

1 reference

23 September 2017

1 reference

23 September 2017

volume

28

1 reference

23 September 2017

issue

5

1 reference

23 September 2017

page(s)

499-506

1 reference

Osteoprogenitor cells within skeletal muscle

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900413-6

7 January 2021

Gene therapy via primary myoblasts: long-term expression of factor IX protein following transplantation in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900413-6

7 January 2021

Systemic delivery of human growth hormone by injection of genetically engineered myoblasts.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900413-6

7 January 2021

Characterization of cells with osteogenic potential from human marrow

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900413-6

7 January 2021

Gene transfer into skeletal muscles by isogenic myoblasts

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900413-6

7 January 2021

Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900413-6

7 January 2021

Effects of recombinant human bone morphogenetic protein-2 on differentiation of cells isolated from human bone, muscle, and skin

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900413-6

7 January 2021

Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900413-6

7 January 2021

Clonal isolation of muscle-derived cells capable of enhancing muscle regeneration and bone healing

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900413-6

7 January 2021

Regional gene therapy with a BMP-2-producing murine stromal cell line induces heterotopic and orthotopic bone formation in rodents

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900413-6

7 January 2021

Adenovirus-mediated direct gene therapy with bone morphogenetic protein-2 produces bone

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900413-6

7 January 2021

Development of approaches to improve cell survival in myoblast transfer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900413-6

7 January 2021

Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900413-6

7 January 2021

Use of a recombinant retrovirus to study post-implantation cell lineage in mouse embryos

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900413-6

7 January 2021

Bone morphogenetic proteins: an update on basic biology and clinical relevance

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900413-6

7 January 2021

Synthesis and processing of genetically modified human proinsulin by rat myoblast primary cultures

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900413-6

7 January 2021

Bone: formation by autoinduction

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900413-6

7 January 2021

Recombinant human bone morphogenetic protein induces bone formation

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900413-6

7 January 2021

Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900413-6

7 January 2021

Bone formation with use of rhBMP-2 (recombinant human bone morphogenetic protein-2)

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900413-6

7 January 2021

10.1016/S8756-3282(01)00413-6

Identifiers

DOI

1 reference

23 September 2017

1 reference